Gavin P. Reynolds
Department of Biomedical Science
The University of Sheffield
UK
Name/email consistency: high
- Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models. Reynolds, G.P., Abdul-Monim, Z., Neill, J.C., Zhang, Z.J. Neurotox. Res (2004)
- Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Reynolds, G.P., Zhang, Z., Zhang, X. Am. J. Psychiatry (2003)
- Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Reynolds, G.P., Zhang, Z.J., Zhang, X.B. Lancet (2002)
- Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons. Reynolds, G.P., Beasley, C.L., Zhang, Z.J. J. Neural. Transm (2002)
- GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia. Reynolds, G.P., Beasley, C.L. J. Chem. Neuroanat. (2001)
- Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Reynolds, G.P., Zhang, Z.J., Beasley, C.L. Brain Res. Bull. (2001)
- The new antipsychotics--some pharmacological aspects of their problems and potential. Reynolds, G.P. Expert. Opin. Pharmacother (2000)
- Symposia: maternal stress, motor neuron disease, antidepressants, and schizophrenia. Reynolds, G. IDrugs (2000)
- 5-HT receptors, genes and antipsychotic mechanisms. Reynolds, G.P. J. Psychopharmacol. (Oxford) (1997)
- What is an atypical antipsychotic?. Reynolds, G.P. J. Psychopharmacol. (Oxford) (1997)
